Nirav Shah to Disease Progression
This is a "connection" page, showing publications Nirav Shah has written about Disease Progression.
Connection Strength
0.027
-
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. Cancer Med. 2020 11; 9(22):8468-8479.
Score: 0.027